SPOTLIGHT: Biotechs cautious about stem cell project
California biotech companies applauded a decision by Gov. Arnold Schwarzenegger (CA) to provide $150 million in loans to the state's stem cell institute to begin funding research, but added that they were nervous about the future of the state's program, which is involved in two lawsuits challenging its constitutionality. Report
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
